(Q33491675)

27 July 2017

1 reference

title

Fotemustine in the treatment of brain primary tumors and metastases (English)

1 reference

27 July 2017

Khayat D

1

1 reference

27 July 2017

Giroux B

2

1 reference

27 July 2017

Berille J

3

1 reference

27 July 2017

Cour V

4

1 reference

27 July 2017

Gerard B

5

1 reference

27 July 2017

Sarkany M

6

1 reference

27 July 2017

Bertrand P

7

1 reference

27 July 2017

Bizzari JP

8

1 reference

27 July 2017

1 January 1994

1 reference

27 July 2017

1 reference

27 July 2017

12

1 reference

27 July 2017

4

1 reference

27 July 2017

414-420

1 reference

A new method for the measurement of nitrosoureas in plasma: an h.p.l.c. procedure for the measurement of fotemustine kinetics

27 July 2017

1 reference

https://api.crossref.org/works/10.3109%2F07357909409038234

Comparative diffusion study of two nitrosoureas: carmustine and fotemustine in normal rat brain, human and rat brain biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409038234

Phase II study of fotemustine in recurrent supratentorial malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409038234

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409038234

The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409038234

Chemotherapy by fotemustine in cerebral metastases of disseminated malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409038234

Chemotherapy for brain metastases: recent developments and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409038234

Cerebral metastases as first symptom of bronchogenic carcinoma. A prospective study of 37 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409038234

Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409038234

Positive phase II study in the treatment of advanced malignant melanoma with fotemustine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409038234

10.3109/07357909409038234

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference